Skip to main content
. 2022 Feb 8;14(3):839. doi: 10.3390/cancers14030839

Figure 4.

Figure 4

Overview of the possible pathogenesis of moyamoya disease in patients with germline CBL mutations. The role of CBL mutations in the genesis of vascular anomalies remains to be fully uncovered, particularly regarding the unknown mechanism that drives lymphocyte infiltration.